Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,442 across all filing types
Latest filing 2019-11-19 Board/Management Inform…
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Imugene appoints Prof Prasad S Adusumilli of MSKCC to OV SAB 3 pages 129.8KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement about the appointment of Professor Prasad S. Adusumilli to the Oncolytic Virotherapy Scientific Advisory Board of Imugene Limited. It contains no financial data, no report or results, no voting or dividend information, and no regulatory or legal filings. It is a corporate announcement about a management/scientific advisory board appointment. This fits best under Board/Management Information (MANG) as it announces a change/addition to the company's advisory board. The document length is 5570 characters, which is consistent with a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2019-11-19 English
Change of Director's Interest Notice - AH 2 pages 174.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares and options held before and after the change, nature of the change, and dates. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of director's securities transactions.
2019-11-18 English
Change of Director's Interest Notice - CW 2 pages 176.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares and options held before and after the change, nature of the change, and dates. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or management report. It fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4233 characters, which is consistent with a detailed director's dealing notice. Therefore, the correct classification is DIRS.
2019-11-18 English
Change of Director's Interest Notice - LR 2 pages 174.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of securities held before and after the change, nature of the change, and dates. This is a formal notification of a director's personal share transactions or interests. The document is short (4191 characters) and focused solely on director share interest changes, matching the definition of Director's Dealing filings. There is no indication of financial results, management changes, or other report types. Therefore, the correct classification is Director's Dealing (DIRS).
2019-11-18 English
Change of Director's Interest Notice - JE 2 pages 173.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of securities held before and after the change, nature of the change, and dates. This is a formal notification of a director's personal share transactions, specifically the acquisition of unlisted options. There is no financial performance data, earnings information, or management discussion. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4198 characters, which is consistent with a detailed notice rather than a full report or announcement of a report. Therefore, the correct classification is DIRS.
2019-11-18 English
Results of Meeting - Oncolytic Virus Acquisition Complete 1
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement titled 'RESULTS OF GENERAL MEETING – Oncolytic Virus Acquisition Complete' dated 18 November 2019. It provides detailed voting results for resolutions passed at a General Meeting, including approval of share allotments and acquisition. The content focuses on the official results of shareholder votes at a general meeting, which matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is short (2028 characters) and it is not a report itself but an announcement of voting outcomes. Therefore, the correct classification is DVA with high confidence.
2019-11-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.